|제목||PharmAbcine, non-confidential slide deck Q3 2022|
Notice of Changes:
1. Updates on status of clinical activities
2. Potential market size of each pipeline’s indications
3. Addition of new preclinical data at AACR 2022 and BIO USA 2022. (PMC-309)
4. Future milestones of the Company’s R&D activities
Please check the attached file for details.
We would like to thank our shareholders, investors, and partners for their continued support.